Hey there, fellow market adventurers! It's Meta Matt here again, and you guessed it; it's time to dive back into another one of Lee's August Stock Market thesis, where we'll unravel the intriguing world of market trends and opportunities. So, buckle up and let's break down what's been brewing in the financial landscape.
Hey there, fellow market adventurers! It's Meta Matt here again, and you guessed it; it's time to dive back into another one of Lee's August Stock Market thesis, where we'll unravel the intriguing world of market trends and opportunities. So, buckle up and let's break down what's been brewing in the financial landscape.
Dow Jones (DIA) - Battling the Bears
Lee kicked off his thesis with a look at the Dow Jones (DIA), where bears had their say after some spirited price action the previous week. The bears came out swinging, and they weren't messing around! The Dow Jones was looking a little wobbly with a current stock price of $353 at the time of Lee's Thesis.
But fear not, there's hope on the horizon. Lee had his eyes locked on a crucial support level at $343. This level was like a defensive line at the 1-yard line in the 4th quarter of a close football game – it needed to hold for the bulls to get back in the game. If $343 crumbled like a house of cards, brace yourselves for a potential tumble down to $336. The RSI (Relative Strength Index) was still above 50, but it was starting to show signs of weakness. Uh-oh!
Trading Plays for DIA:
Make sure to check out last week's Thesis by Lee: https://blog.pbalerts.com/etfs-we-are-watching-in-august/
Bristol-Myers Squibb (BMY) - The Bullish Trail Continues
Lee's next pick was none other than Bristol-Myers Squibb (BMY). Things were looking pretty upbeat here. BMY notched another green week and seemed to be comfortably situated in the uptrend zone. The name of the game? Higher lows and higher highs to confirm that the bulls were ready to boogie. And guess what? The RSI was showing some bullish divergence on the chart. Cue the confetti!
Trading Update for BMY:
LABU - Riding the Biotech Wave
Now, let's zoom in on Lee's Healthcare ETF pick – LABU, a Bull ETF focused on biotech. Lee had some exciting updates here. LABU had taken a joyride to the low $4 support level, a spot it had last visited in June 2022 and March 2023. But what happened next was like watching Logan Paul's career rise from the ashes after the "forest incident in Japan". The bulls roared back, turning Friday's trading day into a victorious green spectacle!
Trading Opportunity in LABU:
Support and Resistance Dance in LABU:
So there you have it – Lee's weekly thesis decoded for your trading delight. Remember, in the world of finance, knowledge is power. So, keep those eyes on the support levels, watch for those bullish divergences, and may your trades be ever in your favor. Until next time, happy trading! 🚀📈
Check out our FREE Trading Discord to ask Lee any questions!! We also have over 75 FREE Trading Classes!!
https://discord.gg/pennybois
Get crypto education, live streams, real time trade alerts, exclusive NFT deals, and more.
PennyBois is a group of experienced traders dedicated to providing hedge fund quality trade alerts without the cost.